Loading clinical trials...
Loading clinical trials...
Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ Donor to HCVNegative Organ Transplant Recipient - Pilot Trial
Conditions
Interventions
glecaprevir/pibrentasvir (GLE/PIB)
Locations
1
United States
University of California San Diego
San Diego, California, United States
Start Date
May 28, 2021
Primary Completion Date
April 21, 2022
Completion Date
April 21, 2022
Last Updated
May 24, 2022
NCT06953479
NCT04162938
NCT03135886
NCT05968573
NCT01644903
NCT05368974
Lead Sponsor
University of California, San Diego
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions